The Targeted Genomics Facilities Core (TGFC) is part of an integrated Facility Core program consisting of hypothesis generating, testing, and translational resources within an Integrated Discovery Pipeline, designed to accelerate and advance innovative ideas from hypothesis to practice. The goal of the TGFC is to provide CTEHR investigators with access to highly sophisticated and tailored genetically engineered mouse and modified human cell model systems, which can be used to test novel hypothesis generated by Center members doing cutting-edge EHS research. In the last few years there have been important advances in the gene targeting approaches for generating genetically engineered cells and transgenic animals, including gene trap, engineered nuclease (ZFN) and TALEN technologies. The TGFC will provide CTEHR investigators with streamlined and cost effective generation of genetically engineered (and validated) model systems for their research. The TGFC has both the technology and the necessary expertise to develop these models for investigators in all the of the CTEHR Thematic Focus Areas, by applying economies of scale to their production and validation, and by leveraging the resources already available within the participating institutions. The TGFC will facilitate timely research advances through the following Specific Aims:
Aim 1. Maintain the skilled personnel, molecular technologies and research infrastructure necessary for the generation of state-of-the-art genetically engineered model systems to support CTEHR research.
Aim 2. Provide members with cost effective, prioritized access to services that support the development and use of genetically engineered model systems (cell lines and transgenic mice) to study interactions between the genome and environmental factors that impact human health and disease.
Aim 3. Educate CTEHR members about the application of state-of-the-art genetic engineering technologies to research on the effects of environmental factors on human health and support the career development and mentoring activities of Center investigators Aim 4. Facilitate the translational research activities on the interactions between the genome and environmental factors that impact human health through interactions with the other CTEHR Facility Cores and Programs. The TGFC will provide access to powerful research technologies that will enable CTEHR members to develop and test innovative hypotheses focusing on genome - environment interactions, and their effect on human health. This Core provides the opportunity to evaluate and validate new concepts in genetically relevant model systems as part of integrated "discovery pipeline" involving hypothesis generation, testing and translation. Use of this pipeline will accelerate the process of advancing innovative ideas and translating them to improvement of environmental health and mitigation of environmental disease.

Public Health Relevance

Program Narrative - Targeted Genomics Facility Core The Targeted Genomics Facility Core (TGFC) provides an important link in the discovery research program of the CTEHR by providing trainees and investigators with access to sophisticated model systems that are critical to the study of the interactions between the genome and environmental factors that contribute to human health and disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Center Core Grants (P30)
Project #
1P30ES023512-01
Application #
8619331
Study Section
Environmental Health Sciences Review Committee (EHS)
Project Start
Project End
Budget Start
2014-06-05
Budget End
2015-03-31
Support Year
1
Fiscal Year
2014
Total Cost
$81,876
Indirect Cost
$11,255
Name
Texas A&M Agrilife Research
Department
Type
DUNS #
847205713
City
College Station
State
TX
Country
United States
Zip Code
77843
Phillips, Tracie D; Richardson, Molly; Cheng, Yi-Shing Lisa et al. (2015) Mechanistic relationships between hepatic genotoxicity and carcinogenicity in male B6C3F1 mice treated with polycyclic aromatic hydrocarbon mixtures. Arch Toxicol 89:967-77
Lee, Syng-Ook; Li, Xi; Hedrick, Erik et al. (2014) Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells. Mol Endocrinol 28:1729-39
Nair, Vijayalekshmi; Sreevalsan, Sandeep; Basha, Riyaz et al. (2014) Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors. J Biol Chem 289:27692-701
Jutooru, Indira; Guthrie, Aaron S; Chadalapaka, Gayathri et al. (2014) Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents. Mol Cell Biol 34:2382-95
Kang, Y; Nian, H; Rajendran, P et al. (2014) HDAC8 and STAT3 repress BMF gene activity in colon cancer cells. Cell Death Dis 5:e1476
Stossi, Fabio; Bolt, Michael J; Ashcroft, Felicity J et al. (2014) Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assays. Chem Biol 21:743-53
Lingappan, Krithika; Jiang, Weiwu; Wang, Lihua et al. (2014) Mice deficient in the gene for cytochrome P450 (CYP)1A1 are more susceptible than wild-type to hyperoxic lung injury: evidence for protective role of CYP1A1 against oxidative stress. Toxicol Sci 141:68-77
Allen, M Jeannie; Fan, Yang-Yi; Monk, Jennifer M et al. (2014) n-3 PUFAs reduce T-helper 17 cell differentiation by decreasing responsiveness to interleukin-6 in isolated mouse splenic CD4? T cells. J Nutr 144:1306-13
Knight, Jason M; Davidson, Laurie A; Herman, Damir et al. (2014) Non-invasive analysis of intestinal development in preterm and term infants using RNA-Sequencing. Sci Rep 4:5453